Streptococcus anginosus (milleri) Group Strains Isolated in Poland (1996-2012) and their Antibiotic Resistance

Insights

The Streptococcus Anginosus Group (SAG) causes purulent infections but is often misidentified. This study analyzed SAG strains in Poland, finding them diverse and mostly sensitive to penicillin but resistant to tetracycline and macrolides.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Epidemiology

Background:

  • The Streptococcus Anginosus Group (SAG), previously known as the
  • milleri
  • group, comprises Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus.
  • These bacteria are increasingly recognized as pathogens causing purulent infections, though their prevalence is likely underestimated due to misclassification as
  • viridans streptococci
  • in clinical laboratories.

Purpose of the Study:

  • To investigate the epidemiological situation and antibiotic resistance patterns of SAG infections in Poland.
  • To re-identify and characterize SAG strains isolated between 1996 and 2012.
  • To assess the genetic diversity of SAG strains in Poland.

Main Methods:

  • Retrospective analysis of SAG strains isolated in Poland from 1996–2012.
  • Strain identification using automated Vitek2 system and MALDI-TOF MS.
  • Antibiotic susceptibility testing via Vitek2, disk diffusion, and E-Tests; PCR for resistance determinants.
  • Genomic typing using Pulse Field Gel Electrophoresis (PFGE) and Multiple Locus Variable Number Tandem Repeats (MLVF) analysis.

Main Results:

  • SAG strains were rarely isolated in Poland, primarily from purulent infections.
  • Automated methods showed limitations in distinguishing between SAG species and in MIC evaluation.
  • Genomic analysis revealed significant diversity among the analyzed SAG strains.
  • All isolates were sensitive to penicillin; however, a substantial proportion exhibited resistance to macrolides and the majority were resistant to tetracycline.

Conclusions:

  • SAG infections in Poland are underreported, and current automated diagnostic methods require improvement for accurate species identification and susceptibility testing.
  • The genetic diversity of SAG strains suggests multiple origins or adaptation mechanisms.
  • Antibiotic resistance patterns highlight the need for careful treatment selection, particularly concerning macrolides and tetracyclines.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
37
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
7
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
8
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
14
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
2